FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt

Huadong Pei, Liang Li, Brooke L. Fridley, Gregory D. Jenkins, Krishna R. Kalari, Wilma Lingle, Gloria Petersen, Zhenkun Lou, Liewei Wang

Research output: Contribution to journalArticlepeer-review

433 Scopus citations


Akt is a central regulator of cell growth. Its activity can be negatively regulated by the phosphatase PHLPP that specifically dephosphorylates the hydrophobic motif of Akt (Ser473 in Akt1). However, how PHLPP is targeted to Akt is not clear. Here we show that FKBP51 (FK506-binding protein 51) acts as a scaffolding protein for Akt and PHLPP and promotes dephosphorylation of Akt. Furthermore, FKBP51 is downregulated in pancreatic cancer tissue samples and several cancer cell lines. Decreased FKBP51 expression in cancer cells results in hyperphosphorylation of Akt and decreased cell death following genotoxic stress. Overall, our findings identify FKBP51 as a negative regulator of the Akt pathway, with potentially important implications for cancer etiology and response to chemotherapy.

Original languageEnglish (US)
Pages (from-to)259-266
Number of pages8
JournalCancer cell
Issue number3
StatePublished - Sep 8 2009



ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research


Dive into the research topics of 'FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt'. Together they form a unique fingerprint.

Cite this